The false narrative of "the easy way out" One of the most significant misconceptions about semaglutide and GLP-1 medications is that they are a "quick fix" or an "easy way out" for managing diabetes
The table lists 10-15% of body weight for semaglutide, citing the STEP program, and 20-22% for tirzepatide, citing the SURMOUNT trials
Counterfeit Botox that sickened people across the country in April 2024 (FDA) An August 2025 expos in Elle about bad actors and loose regulation in the medical spa industry included the story of a Boston woman who falsely claimed to be a registered nurse and injected patients with counterfeit products from Brazil and China
Injection timing has no effect on cost
On a GLP-1, appetite shrinks but protein needs do not, so the quick-add protein tracker earns its place on the home screen: eggs, yogurt, a shake, a chicken thigh, each one tap
Side effect and symptom logging Record side effects and symptoms alongside injection events